Amplius Wealth Advisors’s Veracyte VCYT Stock Holding History

Amplius Wealth Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-74	Closed	-$3K	–	873
2021 Q4	$3K	Buy	+74	New	+$3.27K	﹤0.01%	813

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Amplius Wealth Advisors's VCYT Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 74 shares — an estimated $3K sold.

Amplius Wealth Advisors first reported a position in VCYT in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

Amplius Wealth Advisors reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
Amplius Wealth Advisors sold 74 Veracyte shares in Q1 2022, an estimated $3K.
Amplius Wealth Advisors first reported a position in Veracyte in Q4 2021 and held it in 1 quarter.
Amplius Wealth Advisors's Veracyte position peaked at $3K in Q4 2021.
205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.